A Prospective Five-Year Follow-up After peg-Interferon Plus Nucleotide Analogue Treatment or no Treatment in HBeAg Negative Chronic Hepatitis B Patients.

J Clin Exp Hepatol · 2022 · PMC9168707 · PMID 35677522

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

showed a trendP < 0.06so close (0.05 < p ≤ 0.1)

Variables that were significantly associated with HBsAg-loss or showed a trend ( P < 0.06) in a univariable regression analysis, were included in the multivariable logistic regression analysis Table 2 .

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.